Gardasil News and Research

RSS

Gardasil is a vaccine that prevents the types of genital human papillomavirus (HPV) that cause most cases of cervical cancer and genital warts. The vaccine, Gardasil, is given in three shots over six-months. The vaccine is routinely recommended for 11 and 12 year old girls. It is also recommended for girls and women age 13 through 26 who have not yet been vaccinated or completed the vaccine series.

Her son’s injury never got its day in vaccine court. Their lawyer is now advising RFK on its overhaul.

In 2019, after a routine vaccination, 11-year-old Keithron Thomas felt a sharp pain in his shoulder and down his arm. His mother, Melanie Bostic, thought it would go away after a few days. But days turned to weeks, then months, and years.

29 Jan 2026

New Cochrane reviews confirm the effectiveness of HPV vaccines in preventing cervical cancer

Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.

24 Nov 2025

HPV16 reprograms immune cells to weaken cancer defenses

The most common cancer-causing strain of human papillomavirus (HPV), HPV16, undermines the body's defenses by reprogramming immune cells surrounding the tumor, according to new research from the Keck School of Medicine of USC.

19 Aug 2025

Vested interests. Influence muscle. At RFK Jr.’s HHS, It’s not pharma. It’s wellness.

On his way to an Ultimate Fighting Championship event, Health and Human Services Secretary Robert F. Kennedy Jr. stopped by the home of podcaster Gary Brecka.

14 Jul 2025

Novel test could improve detection of cervical adenocarcinoma

In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) have developed a test for detecting a type of cervical cancer that Pap tests often miss.

7 Sep 2023

Understanding the cervical microbiome: a promising frontier in HPV treatment

A recent feature published in PNAS provided emerging insights into microflora associated with human papillomavirus (HPV) infections.

26 Apr 2023

Rutgers study uncovers predictors of anal high-risk HPV infection

Previous sexually transmitted infections and more sexual partners predict new human papillomavirus (HPV) infections in men who have sex with men, other cisgender sexual minority men and transgender women, according to a Rutgers study.

7 Sep 2022

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

Australia's first dedicated children's immunotherapy center will investigate treatments to not only increase the survival of kids with cancer, but to also improve their ongoing quality of life.

24 Aug 2022

Revolutionary mRNA vaccine technology: History, facts and the future

mRNA vaccine technology is a field full of promise – as well as unanswered questions – for communities living with the burden of the world’s most deadly infectious diseases.

20 Apr 2022

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

A recent report suggested that a single dose of the human papillomavirus (HPV) vaccination confers equivalent immunity to a two-dose schedule against cervical cancers caused by HPV.

14 Apr 2022

Cervical cancer screening behaviors differ between vaccinated and unvaccinated women

Women who are vaccinated against human papillomavirus (HPV) are more likely to undergo cervical cancer screenings than unvaccinated women, according to new research by Penn State College of Medicine.

7 Dec 2021

Trial positions single-dose HPV vaccination as a high impact public health intervention

In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.

20 Nov 2021

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

A new study published in the preprint server bioRxiv in September 2020 reports on the structure of this protein, as revealed by cryo-electron microscopy (cryoEM).

23 Sep 2020

Federal experts’ advice on HPV vaccine could leave adults confused

Vaccination decisions are usually pretty straightforward. People either meet the criteria for the vaccine based on their age or other factors or they don't. But when a federal panel recently recommended an update to the human papillomavirus (HPV) vaccine guidelines, it left a lot of uncertainty.

8 Aug 2019

Gardasil News and Research

Further Reading

Her son’s injury never got its day in vaccine court. Their lawyer is now advising RFK on its overhaul.

New Cochrane reviews confirm the effectiveness of HPV vaccines in preventing cervical cancer

HPV16 reprograms immune cells to weaken cancer defenses

Vested interests. Influence muscle. At RFK Jr.’s HHS, It’s not pharma. It’s wellness.

Novel test could improve detection of cervical adenocarcinoma

Understanding the cervical microbiome: a promising frontier in HPV treatment

Rutgers study uncovers predictors of anal high-risk HPV infection

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

Revolutionary mRNA vaccine technology: History, facts and the future

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

Cervical cancer screening behaviors differ between vaccinated and unvaccinated women

Trial positions single-dose HPV vaccination as a high impact public health intervention

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

Federal experts’ advice on HPV vaccine could leave adults confused

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

Sylvester dermatologist uses HPV vaccine to treat patient with squamous cell tumors

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

The ratcheting cost of the pneumococcal vaccine: What gives?

HPV-related oropharyngeal cancer risk remains generally low, study suggests

Five important things everyone should know about cervical cancer

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News